Prothena Corp

PRTA NASDAQ
6.89
-0.39
-5.36%
After Hours: 6.89 0 0.00% 16:41 08/23 EDT
Open
7.23
Prev Close
7.28
High
7.30
Low
6.84
Volume
184.07K
Avg Vol (3M)
231.22K
52 Week High
15.91
52 Week Low
6.84
% Turnover
0.46%
Market Cap
274.89M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Prothena Corp PRTA stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Prothena Corporation Public Limited Company is a global biotechnology company. The Company is focused on the discovery, development and commercialization of immunotherapies for the treatment of diseases that involve protein misfolding or cell adhesion. The Company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004). The Company has generated monoclonal antibodies that selectively bind to amyloidogenic (diseased) forms of the Transthyretin (TTR)-mediated amyloidosis (ATTR) protein. The Company's pipeline also includes late discovery-stage programs for which the Company is testing the efficacy of antibodies in preclinical models of diseases related to amyloid or cell adhesion.
MORE >

Recently

Name
Price
%Change